EMEA-002708-PIP02-21
Key facts
| Active substance |
Verdiperstat
|
| Therapeutic area |
Neurology
|
| Decision number |
P/0523/2021
|
| PIP number |
EMEA-002708-PIP02-21
|
| Pharmaceutical form(s) |
Modified-release tablet
|
| Condition(s) / indication(s) |
Treatment of amyotrophic lateral sclerosis
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Biohaven Pharmaceutical Ireland DAC
Email: medinfo@biohavenpharma.com |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|